Skip to the page

Data / Drug companies / Almon Healthcare Private Limited

Almon Healthcare Private Limited: 19 products in the FDA NDC directory, labeler code 84241

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Almon Healthcare Private Limited (labeler code 84241) lists 19 products in the FDA National Drug Code Directory. By type: 19 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on June 20, 2025.

The request: Watch Almon Healthcare Private Limited (FDA labeler code 84241): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
84241
Products in commercial distribution
19
Packages
50
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Started marketing in the last 12 months
0
Products with a marketing end date set
10
Earliest marketing start
May 20, 2024
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients19100%

Products by type

TypeProductsShare
Bulk ingredients19100%

Dosage forms

Dosage formProductsShare
Powder19100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Enclomiphene citrate84241-110PowderBulk ingredientsJune 20, 2025
Nicotinamide adenine dinucleotide84241-113PowderBulk ingredientsNovember 1, 2024
Nicotinamide adenine dinucleotide84241-113PowderBulk ingredientsNovember 1, 2024
Tofacitinib citrate84241-112PowderBulk ingredientsNovember 1, 2024
Tofacitinib citrate84241-112PowderBulk ingredientsNovember 1, 2024
Sildenafil citrate84241-111PowderBulk ingredientsNovember 1, 2024
Sildenafil citrate84241-111PowderBulk ingredientsNovember 1, 2024
Enclomiphene citrate84241-110PowderBulk ingredientsNovember 1, 2024
Enclomiphene citrate84241-110PowderBulk ingredientsNovember 1, 2024
Clomiphene cirtate84241-101PowderBulk ingredientsNovember 1, 2024
Prednisolone84241-109PowderBulk ingredientsJuly 1, 2024
Deflazacort84241-108PowderBulk ingredientsJuly 1, 2024
Oxcarbazepine84241-107PowderBulk ingredientsJuly 1, 2024
Mirabegron84241-106PowderBulk ingredientsJuly 1, 2024
Epinephrine84241-105PowderBulk ingredientsJune 1, 2024
Naltrexone hydrochloride84241-104PowderBulk ingredientsJune 1, 2024
Moxifloxacin hcl84241-103PowderBulk ingredientsMay 21, 2024
Apixaban84241-102PowderBulk ingredientsMay 21, 2024
Clomiphene cirtate84241-101PowderBulk ingredientsMay 20, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.